Prelude Therapeutics (PRLD)
(Delayed Data from NSDQ)
$1.50 USD
+0.28 (22.95%)
Updated Sep 26, 2025 04:00 PM ET
After-Market: $1.51 +0.01 (0.67%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Prelude Therapeutics Incorporated's dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PRLD 1.50 +0.28(22.95%)
Will PRLD be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for PRLD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PRLD
Prelude Therapeutics (PRLD) Upgraded to Buy: Here's What You Should Know
After Plunging -31.47% in 4 Weeks, Here's Why the Trend Might Reverse for Prelude Therapeutics (PRLD)
PRLD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Down -39.13% in 4 Weeks, Here's Why You Should You Buy the Dip in Prelude Therapeutics (PRLD)
Other News for PRLD
Is PRLD showing upside potential? New Uptrend shows up after soaring 22.95%
PRLD rises 4.27% on September 25, leaving the technical picture intact
Is PRLD positioned for a breakout? Crossed Above 20 Day Moving Average shows up after rallying 13.59%
Stochastic Buy Signal appears for PRLD after 1.98% move
Crossed Above 50 Day Moving Average appears for PRLD after 2.56% move